Life Sciences Venture Capital Firm Burrill To Set Up An India-focused Fund

Wed, 04/11/2007 - 02:42 — Sahad P V

Burrill & Co., a leading US-based life sciences merchant bank-cum-venture capital fund, is raising two funds - one focused on India and the other on China, according to VentureWire.

Each fund is expected to raise between $100 million and $200 million.

The San Francisco-based firm is a life sciences merchant bank focused exclusively on companies involved in biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies, nutraceuticals and wellness, agricultural biotechnology, and industrial biotechnology (biomaterials/bioprocesses) with over $500 million under management.

Burrill's technical and venture investing capability spans the entire spectrum of life sciences.

Comments

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

More information about formatting options



Job By Category

View All

Job By Location

View All
Indepth
Doing Due Diligence Of A Company In "Troubled Waters"
SUJJAIN TALWAR & RAMYA MOHAN, ECONOMIC LAWS PRACTISE
Companies in ‘troubled waters’ normally pay less attention to compliance matters.
What Regulation Applies if No Exemption is Granted?
SAHIL SHAH & VAIDYANATHAN IYER, NISHITH DESAI ASSOCIATES
No convincing argument was made by the promoters to SEBI for obtaining the exemption in the case of Citadel Realty.
» See All
Interviews
Infrastructure Continues To Be Strong Story On AIM
By SHRIJA AGRAWAL
AIM head brushes aside the shareholder activism dampener as specific to just a few cos & not a wide phenomenon.
'Easy Exits In 2-3 Years May Be A Thing Of The Past’
By SHRIJA AGRAWAL
Siguler Guff's Praneet Singh says PE Funds need to tighten processes and operations.
» See All

Recent Comments